miR-122 promotes virus-induced lung disease by targeting SOCS1.
Collison AM, Sokulsky LA, Kepreotes E, Pereira de Siqueira A, Morten M, Edwards MR, Walton RP, Bartlett NW, Yang M, Nguyen TH, Johnston SL, Foster PS, Mattes J.
Collison AM, et al. Among authors: sokulsky la.
JCI Insight. 2021 Apr 8;6(7):e127933. doi: 10.1172/jci.insight.127933.
JCI Insight. 2021.
PMID: 33830082
Free PMC article.
Clinical Trial.